Improving HPV vaccination rates in rural communities
ReMARk: A Multi-level Intervention Addressing Disparities in Rural HPV-related Cancer Prevention: Part 3- Evaluation
This study is testing different ways to help parents in rural North Central Florida get their kids aged 9 to 12 vaccinated against HPV to see if it can improve vaccination rates.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 4630 (estimated) |
| Ages | 8 Years to 99 Years |
| Sex | All |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Gainesville, Florida) |
| Trial ID | NCT06535139 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance the effectiveness of HPV vaccine recommendations in rural North Central Florida by evaluating various implementation strategies. It focuses on parent-targeted motivational aids and community healthcare access assistance, assessing their clinical and cost-effectiveness. The study will also analyze how patient-level factors, such as age and social vulnerability, influence the effectiveness of these strategies. By addressing barriers faced by clinicians, parents, and healthcare access, the study seeks to improve vaccination rates among 9- to 12-year-olds.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 9 to 12 years who have not yet received both doses of the HPV vaccine and have visited a participating clinic in the past year.
Not a fit: Patients outside the age range of 8 to 12 years or those whose providers are unwilling to consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly increase HPV vaccination rates in rural communities, reducing cancer disparities.
How similar studies have performed: Other studies have shown success in using similar community-targeted approaches to improve vaccination rates, indicating that this method is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adolescents Age 8- to 12-years-old Visited participating clinic in past year or during study No records of receiving both HPV vaccine doses * Providers Provide 9- to 12-year-old patients primary care Practice at a participating clinic Exclusion Criteria: * Adolescents Out of age range * Providers Unwilling to consent
Where this trial is running
Gainesville, Florida
- University of Florida — Gainesville, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Stephanie Staras, PhD — University of Florida
- Study coordinator: Stephanie Staras, PhD
- Email: sstaras@ufl.edu
- Phone: 352-294-8299
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.